| Detected | Trial | Change |
|---|---|---|
| 2026-06-05 | NCT06702631 Nitrous Oxide Neuroimaging |
date change Primary completion pushed: 2026-06-01 -> 2026-09-01 |
| 2026-06-05 | NCT06702631 Nitrous Oxide Neuroimaging |
date change Completion pushed: 2026-06-01 -> 2026-09-01 |
| 2026-05-15 | NCT05357066 Nitrous Oxide as Treatment for Fibromyalgia |
overall status: "Recruiting" → "Withdrawn" |
| 2026-05-15 | NCT05357066 Nitrous Oxide as Treatment for Fibromyalgia |
critical why stopped: null → "PI has left university" |
| 2026-05-15 | NCT05357066 Nitrous Oxide as Treatment for Fibromyalgia |
Enrollment reduced: 50 -> 0 participants |
| 2026-05-15 | NCT05357066 Nitrous Oxide as Treatment for Fibromyalgia |
date change Primary completion moved earlier: 2027-06-01 -> 2026-02-27 |
| 2026-05-15 | NCT05357066 Nitrous Oxide as Treatment for Fibromyalgia |
date change Completion moved earlier: 2027-12-01 -> 2026-02-27 |
| 2026-05-15 | NCT05357040 Antidepressant Effects of Nitrous Oxide |
overall status: "Recruiting" → "Withdrawn" |
| 2026-05-15 | NCT05357040 Antidepressant Effects of Nitrous Oxide |
critical why stopped: null → "PI has left the university" |
| 2026-05-15 | NCT05357040 Antidepressant Effects of Nitrous Oxide |
Enrollment reduced: 172 -> 0 participants |
| 2026-05-15 | NCT05357040 Antidepressant Effects of Nitrous Oxide |
date change Primary completion moved earlier: 2026-10-01 -> 2026-02-27 |
| 2026-05-15 | NCT05357040 Antidepressant Effects of Nitrous Oxide |
date change Completion moved earlier: 2026-12-01 -> 2026-02-27 |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-11 | NCT07643103 Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative… | Phase 2 | Not Yet Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05895383 | Self-Adjusted Nitrous Oxide: A Feasibility Study in the Setting of Vasectomy | Procedural Pain | Recruiting |
| Phase 3 | |||
| NCT03959085 | Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT03150693 | Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT07476729 | International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020… | B-Cell Acute Lymphoblastic Leukaemia | Not Yet Recruiting |
| Phase 2 | |||
| NCT06533748 | Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia… | Acute Lymphoblastic Leukemia | Recruiting |
| NCT05645718 | Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and… | Leukemia | Recruiting |
| NCT02877303 | Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in… | B Acute Lymphoblastic Leukemia | Recruiting |
| NCT03739814 | Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients… | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Recruiting |
| NCT02981628 | Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or… | Recurrent B Acute Lymphoblastic Leukemia | Recruiting |
| NCT04747912 | Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With… | Lymphoblastic Leukemia | Recruiting |
| NCT05748171 | A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in… | ACUTE LYMPHOBLASTIC LEUKEMIA | Recruiting |
| NCT03441061 | Inotuzumab Ozogamicin in Treating Patients With B-cell Acute Lymphocytic Leukemia With… | Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT05303792 | Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to… | B Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| NCT05456698 | Efficacy and Safety of Inotuzumab Ozogamicin in Treating Adult Patients With Ph Negative… | Acute Lymphocytic Leukemia | Active, Not Recruiting |
| NCT07643103 | Immuno-Targeted Therapy Plus Low-Dose Chemotherapy for Newly Diagnosed Adult Ph-Negative… | Ph- Acute Lymphoblastic Leukemia (Ph-ALL) | Not Yet Recruiting |
| Phase 1/2 | |||
| NCT06287229 | Phase Ib/II Study Assessing the Clinical Activity and Safety of Brexucabtagene Autoleucel… | Relapsed/Refractory | Recruiting |
| NCT04231760 | The Effect of Inhaled Nitric Oxide on Pulmonary Gas-exchange in COPD | Chronic Obstructive Pulmonary Disease | Not Yet Recruiting |
| Phase 1 | |||
| NCT05871606 | Inhaled Nitric Oxide in Acute Ischemic Stroke Patients Undergoing Mechanical Thrombectomy | Cerebrovascular Disorders | Recruiting |
| NCT02994433 | NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits | Depressive Disorder, Major | Recruiting |
| NCT05016947 | Venetoclax Plus Inotuzumab for B-ALL | B-cell Acute Lymphoblastic Leukemia | Active, Not Recruiting |
| Early Phase 1 | |||
| NCT06702631 | Nitrous Oxide Neuroimaging | Anesthesia | Recruiting |
| Not specified | |||
| NCT07491874 | Use of Nitrous Oxide for Pain and Anxiety Management During Cervical Cerclage Removal | Preterm Delivery | Not Yet Recruiting |
| NCT07544147 | Inhaled Nitric Oxide for Prevention of Postoperative AKI in High-Risk Cardiac Surgery… | Cardiac Surgery Associated - Acute Kidney Injury | Not Yet Recruiting |